| CSF1R Protein (Colony Stimulating Factor 1 Receptor) | |
|---|---|
| Pathway | Function |
| **PI3K/AKT** | Survival, metabolic regulation |
| **RAS/RAF/MEK/ERK** | Proliferation, differentiation |
| **JAK/STAT** | Gene expression, activation |
| **SRC Family Kinases** | Cytoskeletal remodeling, phagocytosis |
| Compound | Status |
| **PLX3397 (Pexidartinib)** | FDA approved |
| **BLZ945** | Clinical trials |
| **PLX5622** | Preclinical/Clinical |
| **JNJ-40346527** | Phase II |
| Interactor | Type |
| **CSF-1** | Ligand |
| **IL-34** | Ligand |
| **SRC** | Kinase |
| **PI3K** | Kinase |
| **GRB2** | Adaptor |
| **STAT3** | TF |
| **TREM2** | Receptor |
| **DAP12** | Adaptor |
| Associated Diseases | ALS, Als, CANCER, Cancer, Carcinoma |
| KG Connections | 164 edges |
CSF1R Protein
| Symbol: | CSF1R |
| Also known as: | c-FMS, CD115, M-CSFR |
| UniProt: | [P07333](https://www.uniprot.org/uniprot/P07333) |
| Gene: | [CSF1R](/genes/csf1r) |
| MW: | 107.6 kDa |
| Location: | Cell membrane |
| PDB: | [3LCD](https://www.rcsb.org/structure/3LCD), [4W7E](https://www.rcsb.org/structure/4W7E) |
Pathway Diagram
flowchart TD
CSF1R["CSF1R"]
style CSF1R fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0
Als["Als"]
CSF1R -->|"activates"| Als
Blood_Brain_Barrier["Blood-Brain Barrier"]
CSF1R -->|"activates"| Blood_Brain_Barrier
microglia["microglia"]
CSF1R -->|"regulates"| microglia
MICROGLIA["MICROGLIA"]
CSF1R -->|"inhibits"| MICROGLIA
Leukemia["Leukemia"]
CSF1R -->|"activates"| Leukemia
Ms["Ms"]
CSF1R -->|"activates"| Ms
CSF1R -->|"inhibits"| Ms
Depression["Depression"]
CSF1R -->|"inhibits"| Depression
PLX3397["PLX3397"]
PLX3397 -->|"inhibits"| CSF1R
dasatinib["dasatinib"]
dasatinib -->|"inhibits"| CSF1R
PLX5622["PLX5622"]
PLX5622 -->|"inhibits"| CSF1R
BDNF["BDNF"]
BDNF -->|"associated with"| CSF1R
AMYLOID["AMYLOID"]
AMYLOID -->|"associated with"| CSF1R
style Als fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0
style Blood_Brain_Barrier fill:#5d4400,stroke:#4fc3f7,color:#e0e0e0
style microglia fill:#888,stroke:#4fc3f7,color:#e0e0e0
style MICROGLIA fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0
style Leukemia fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0
style Ms fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0
style Depression fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0
style PLX3397 fill:#006494,stroke:#4fc3f7,color:#e0e0e0
style dasatinib fill:#006494,stroke:#4fc3f7,color:#e0e0e0
style PLX5622 fill:#006494,stroke:#4fc3f7,color:#e0e0e0
style BDNF fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0
style AMYLOID fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0Overview
CSF1R (Colony Stimulating Factor 1 Receptor, also known as c-FMS, CD115, or M-CSFR) is a receptor tyrosine kinase that plays essential roles in microglial development, survival, and function. As the primary receptor for colony stimulating factor 1 (CSF-1, also called M-CSF) and interleukin-34 (IL-34), CSF1R signaling is critical for the maintenance and activation of the brain’s resident immune cells1Colony-stimulating factor 1 receptor signaling is necessary for microglia viabilityOpen reference.
CSF1R mutations cause adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare but devastating neurodegenerative disorder. Additionally, CSF1R signaling is implicated in Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions through its effects on microglial function2Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroidsOpen reference3CSF1R mutations and neurodegenerationOpen reference.
Structure and Domain Architecture
CSF1R is a 972-amino acid transmembrane protein belonging to the platelet-derived growth factor receptor (PDGFR) family:
-
Extracellular Domain (residues 1-512): Contains five immunoglobulin-like (Ig-like) domains responsible for ligand binding:
-
D1-D3: Primary ligand binding sites for CSF-1 and IL-34
-
D4-D5: Receptor dimerization interface4Structure and assembly mechanism of the signaling complex CSF-1/CSF-1ROpen reference
-
-
Transmembrane Domain (residues 513-534): Single-pass α-helix anchoring the receptor
-
Intracellular Domain (residues 535-972): Contains:
-
Juxtamembrane Domain: Autoinhibitory region
-
Tyrosine Kinase Domain (residues 578-910): Split kinase domain with intervening sequence
-
C-terminal Tail: Contains additional tyrosine phosphorylation sites
-
Ligand binding induces receptor dimerization, trans-autophosphorylation, and activation of downstream signaling cascades5CSF-1 receptor signaling in myeloid cellsOpen reference.
Normal Function in the CNS
Microglial Development and Survival
CSF1R is the master regulator of microglial biology:
-
Development: CSF1R signaling is essential for microglial precursor migration from the yolk sac to the developing brain and subsequent proliferation6Fate mapping analysis reveals that adult microglia derive from primitive macrophagesOpen reference.
-
Survival: Continuous CSF1R signaling is required for microglial survival. CSF1R inhibition or knockout leads to rapid microglial depletion7Characterizing newly repopulated microgliaOpen reference.
-
Homeostasis: CSF1R maintains microglial identity and the homeostatic microglial gene expression signature (Tmem119, P2ry12, Siglech).
Signaling Pathways
Upon CSF-1 or IL-34 binding, CSF1R activates multiple downstream pathways:
Microglial Functions
CSF1R-regulated microglial functions include:
-
Synaptic Pruning: Microglia eliminate excess synapses during development
-
Debris Clearance: Phagocytosis of apoptotic cells and protein aggregates
-
Neurotrophic Support: Secretion of growth factors (IGF-1, BDNF)
-
Immune Surveillance: Monitoring for pathogens and damage signals8Microglia emerge as central players in brain diseaseOpen reference
Role in Neurodegeneration
ALSP (CSF1R-Related Disorder)
Heterozygous mutations in CSF1R cause ALSP, characterized by:
-
Clinical Features:
-
Onset typically 40-50 years
-
Cognitive decline, personality changes
-
Motor dysfunction, pyramidal signs
-
Seizures and leukoencephalopathy9Clinical features of CSF1R-related adult-onset leukoencephalopathyOpen reference
-
-
Pathology:
-
White matter degeneration with axonal spheroids
-
Pigmented glia containing lipofuscin
-
Microglial dysfunction and depletion
-
-
Pathogenic Mutations:
-
Over 50 mutations identified
-
Kinase domain mutations most common
-
Both loss-of-function and dominant-negative effects10CSF1R mutations in hereditary diffuse leukoencephalopathy with spheroidsOpen reference
-
-
Mechanism: Mutations impair microglial function, leading to:
-
Defective myelin clearance
-
Accumulation of axonal spheroids
-
Secondary oligodendrocyte and axonal damage
-
Alzheimer’s Disease
CSF1R involvement in AD is complex:
-
DAM Activation: Disease-associated microglia (DAM) show increased CSF1R signaling, promoting neuroinflammation and phagocytosis of Aβ2Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroidsOpen reference0.
-
TREM2 Interaction: TREM2 and CSF1R signaling cooperate to regulate microglial responses to amyloid pathology2Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroidsOpen reference1.
-
Therapeutic Targeting: CSF1R inhibitors reduce microglial proliferation but may impair protective functions.
-
CSF1 Levels: Elevated CSF1 in AD brain correlates with disease severity and may contribute to microglial dysregulation2Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroidsOpen reference2.
Parkinson’s Disease
CSF1R in PD involves:
-
Microglial Activation: α-synuclein aggregates activate microglia via CSF1R-dependent pathways2Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroidsOpen reference3.
-
Neuroinflammation: CSF1R signaling promotes pro-inflammatory cytokine release from microglia.
-
Dopaminergic Neurodegeneration: Microglial activation via CSF1R contributes to dopaminergic neuron loss.
-
Neuroprotective Potential: Some studies suggest CSF1R inhibition may be protective by reducing neuroinflammation2Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroidsOpen reference4.
Multiple Sclerosis
CSF1R contributes to MS pathophysiology:
-
Microglial Activation: Active MS lesions show increased CSF1R+ microglia.
-
Demyelination: CSF1R signaling promotes microglial phagocytosis of myelin.
-
Therapeutic Considerations: CSF1R inhibitors may reduce lesion activity but risk impairing repair2Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroidsOpen reference5.
Therapeutic Targeting
CSF1R Inhibitors
Microglial Depletion Strategy
CSF1R inhibitors can achieve >90% microglial depletion:
-
Benefits:
-
Reduces neuroinflammation
-
Allows study of microglial function
-
May remove dysfunctional microglia2Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroidsOpen reference6
-
-
Risks:
-
Impairs debris clearance
-
Disrupts synaptic homeostasis
-
May worsen pathology in some contexts
-
ALSP Treatment
For CSF1R-related disorder:
-
Hematopoietic Stem Cell Transplantation (HSCT): Restores microglial function by replacing CSF1R-deficient cells2Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroidsOpen reference7.
-
Supportive Care: Symptomatic management of cognitive and motor symptoms.
-
Experimental Approaches: Gene therapy and small molecule chaperones under investigation.
Key Interactions
See Also
References
- Colony-stimulating factor 1 receptor signaling is necessary for microglia viability
- Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids
- CSF1R mutations and neurodegeneration
- Structure and assembly mechanism of the signaling complex CSF-1/CSF-1R
- CSF-1 receptor signaling in myeloid cells
- Fate mapping analysis reveals that adult microglia derive from primitive macrophages
- Characterizing newly repopulated microglia
- Microglia emerge as central players in brain disease
- Clinical features of CSF1R-related adult-onset leukoencephalopathy
- CSF1R mutations in hereditary diffuse leukoencephalopathy with spheroids
- A unique microglia type associated with restricting development of Alzheimer's disease
- TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury
- CSF1 and microglial activation in Alzheimer's disease
- Aggregated alpha-synuclein activates microglia
- CSF1R inhibition protects dopaminergic neurons
- Modulation of CSF1R signaling during demyelination
- Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association
- Hematopoietic stem cell transplantation for CSF1R-related disorder
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.